Showing BioInteractions for D-glucose (DB01914)
BioInteractor utilizes data on drug-target, -enzyme and -transporter associations to provide insight on drug-drug interactions. It allows you to identify, for instance, which drugs act similarly on the same target. Such drugs may have additive pharmacodynamic effects if given concomitantly. Conversely, two drugs may antagonize the beneficial effects of each other by having opposite actions on a specific drug target. BioInteractor uses ranked drug-enzyme association information to predict enzyme-mediated drug interactions that may be clinically relevant.
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Hexokinase-1 substrate | ||
| 1 | Hexokinase-1 substrates | Dextrose, unspecified form, Fludeoxyglucose (18F) |
| 2 | Hexokinase-1 inhibitors | Dextrose, unspecified form |
| 3 | Hexokinase-1 inducers | Dextrose, unspecified form |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Glucokinase substrate | ||
| 1 | Glucokinase substrates | Dextrose, unspecified form, Invert sugar |
| 2 | Glucokinase inducers | Dextrose, unspecified form |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 1 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 1 inhibitors | Butabarbital, Etomidate |
| 2 | Solute carrier family 2, facilitated glucose transporter member 1 substrates | Ascorbic acid, Dextrose, unspecified form, Fludeoxyglucose (18F) |
| 3 | Solute carrier family 2, facilitated glucose transporter member 1 binders | Carboxymethylcellulose |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 2 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 2 ligands | Streptozocin |
| 2 | Solute carrier family 2, facilitated glucose transporter member 2 substrates | Dextrose, unspecified form, Fludeoxyglucose (18F), Invert sugar |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 3 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 3 substrates | Ascorbic acid, Dextrose, unspecified form, Fludeoxyglucose (18F) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 4 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 4 substrates | Ascorbic acid, Dextrose, unspecified form, Fludeoxyglucose (18F) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 5 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 5 substrates | Fludeoxyglucose (18F), Invert sugar |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 6 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 6 substrates | Dextrose, unspecified form, Fludeoxyglucose (18F) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 7 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 7 substrates | Dextrose, unspecified form, Fludeoxyglucose (18F) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 8 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 8 substrates | Dextrose, unspecified form, Fludeoxyglucose (18F) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 9 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 9 inhibitors | Losartan, Probenecid |
| 2 | Solute carrier family 2, facilitated glucose transporter member 9 substrates | Dextrose, unspecified form, Fludeoxyglucose (18F), Uric acid |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 10 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 10 substrates | Dextrose, unspecified form, Fludeoxyglucose (18F) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 11 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 11 substrates | Dextrose, unspecified form, Fludeoxyglucose (18F) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Solute carrier family 2, facilitated glucose transporter member 12 substrate | ||
| 1 | Solute carrier family 2, facilitated glucose transporter member 12 substrates | Dextrose, unspecified form, Fludeoxyglucose (18F) |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Sodium/glucose cotransporter 1 substrate | ||
| 1 | Sodium/glucose cotransporter 1 substrates | Dextrose, unspecified form |
| 2 | Sodium/glucose cotransporter 1 inducers | Clavulanic acid |
| Interacting Group | Interacting Drugs | |
|---|---|---|
| D-glucose is a Sodium/glucose cotransporter 2 substrate | ||
| 1 | Sodium/glucose cotransporter 2 inhibitors | Canagliflozin, Dapagliflozin, Empagliflozin |
| 2 | Sodium/glucose cotransporter 2 antagonists | Dapagliflozin, Ertugliflozin |